Key result
Right ventricular hypertrophy serves as a prognostic marker in pulmonary arterial hypertension, acting initially to lower wall tension before becoming maladaptive in end-stage right heart failure.
Answers are grounded in this paper and cite their sources.
Highlights the prognostic relevance of right ventricular hypertrophy in pulmonary arterial hypertension.
The Greek king Sisyphus was punished by Zeus by being made to carry a huge boulder up a steep hill. Each time he thought he had reached the top, the boulder would roll down and Sisyphus would have to start all over again. Likewise, the right ventricle in patients with pulmonary arterial hypertension (PAH) is punished with every heart beat to cope with a 4–5-fold increase in load for the rest of its life [1]. As a consequence, the low-pressure, thin-walled, crescent-shaped ventricle has to transform into a ventricular shape that is able to pump against such an increased afterload [2]. Right ventricular (RV) hypertrophy is therefore observed in almost all PAH patients. RV hypertrophy is a necessary adaptation to lower RV wall tension, to increase the force generating capacity of the RV cardiomyocytes and to preserve RV–arterial coupling [3]. However, this adaptation might come at a price and becomes maladaptive in the end-stage of RV failure increasing stiffness [4] and oxygen consumption [5]. A recent study clearly demonstrates that right ventricular (RV) hypertrophy is a prognostic marker of pulmonary arterial hypertension, triggering us to rethink the concept of RV hypertrophy http://ow.ly/vD0e30nHvFm
No takes yet. Share an insight, caveat, or question.
Man et al. (2019) conducted an editorial in Pulmonary arterial hypertension. Right ventricular hypertrophy was evaluated. Right ventricular hypertrophy serves as a prognostic marker in pulmonary arterial hypertension, acting initially to lower wall tension before becoming maladaptive in end-stage right heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: